Access the full text.
Sign up today, get DeepDyve free for 14 days.
Payesh, 19
MS MD, PhD MD, Mph MD, D. Ba, PhD MD (2007)
Barriers to patient-physician communication about out-of-pocket costsJournal of General Internal Medicine, 19
K. Knopf, D. Smith, J. Doan, J. Munakata (2011)
Estimating the economic burden of gastric cancer in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
P. Kanavos (2006)
The rising burden of cancer in the developing world.Annals of oncology : official journal of the European Society for Medical Oncology, 17 Suppl 8
D. Parkin, F. Bray, J. Ferlay, P. Pisani (2005)
Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 55
J. Lai, S. Jensen, J. Beaumont, A. Abernethy, P. Jacobsen, K. Syrjala, J. Raizer, D. Cella (2014)
Development of a symptom index for patients with primary brain tumors.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17 1
Katy Heise, Enriqueta Bertrán, M. Andía, C. Ferreccio (2009)
Incidence and survival of stomach cancer in a high-risk population of Chile.World journal of gastroenterology, 15 15
G. Mohammadi, M. Akbari, Y. Mehrabi, A. Motlagh, M. Heidari, S. Ghanbari (2016)
Analysis of Cancer Incidence and Mortality in Iran Using Joinpoint Regression AnalysisIranian Red Crescent Medical Journal, 19
Bazyar Mohamad, Pourreza Abolghasem, Harirchi Iraj, Akbari Elah, M. Mahmood (2012)
Medical and non-medical direct costs of cancers in patients hospitalized in Imam Khomeini cancer institution - 2010Journal of Hospital, 11
E. Mohebbi, A. Nahvijou, Maryam Hadji, Hamideh Rashidian, M. Seyyedsalehi, Saeed Nemati, Mohammad Rouhollahi, K. Zendehdel (2017)
Iran Cancer Statistics in 2012 and Projection of Cancer Incidence by 2035Basic & Clinical Cancer Research, 9
(2014)
Analysis and estimation of the direct and indirect costs of breast cancer in women attending Shahid Ghazi clinic, Tabriz, 2013 of article
Iravani Shahrokh (2013)
Gastric cancer as a multifactorial disease, 11
K. Cocks, M. King, G. Velikova, Marrissa St-James, P. Fayers, Julia Brown (2011)
Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 1
R. Tarricone (2006)
Cost-of-illness analysis. What room in health economics?Health policy, 77 1
K. Katanoda, Megumi Hori, T. Matsuda, A. Shibata, Y. Nishino, M. Hattori, M. Soda, A. Ioka, T. Sobue, H. Nishimoto (2015)
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013.Japanese journal of clinical oncology, 45 4
C. Hirst, J. Ryan, O. Tunceli, Bingcao Wu, D. Kern (2014)
Cost Profile of Patients with Gastric Cancer Using United States Administrative Claims DataValue in Health, 17
A. Zeinalzadeh, R. Hosseini, L. Abdullahi (2015)
Survey of Epidemiology of Cancers in the Patients above 15 Years Old in East Azerbaijan Province, Iran 2013Journal of Ardabil University of Medical Sciences, 15
A. Sadjadi, R. Malekzadeh, M. Derakhshan, A. Sepehr, M. Nouraie, M. Sotoudeh, A. Yazdanbod, B. Shokoohi, A. Mashayekhi, S. Arshi, A. Majidpour, M. Babaei, A. Mosavi, Mosavi Mohagheghi, M. Alimohammadian (2003)
Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from IranInternational Journal of Cancer, 107
Bagher Farhood, G. Geraily, A. Alizadeh (2018)
Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review ArticleIranian Journal of Public Health, 47
(2013)
Cancer incidence and mortality worldwide: GLOBOCAN 2012 v1. 0, IARC cancer base no. 11 of article
K. Langa, A. Fendrick, M. Chernew, Mohammed Kabeto, K. Paisley, J. Hayman (2004)
Out-of-pocket health-care expenditures among older Americans with cancer.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 7 2
C. Fitzmaurice, Christine Allen, Ryan Barber, L. Barregard, Z. Bhutta, H. Brenner, D. Dicker, Odgerel Chimed-Orchir, R. Dandona, L. Dandona, T. Fleming, M. Forouzanfar, Jamie Hancock, Roderick Hay, Rachel Hunter-Merrill, Chantal Huynh, H. Hosgood, C. Johnson, J. Jonas, J. Khubchandani, G. Kumar, Michael Kutz, Q. Lan, H. Larson, Xiaofeng Liang, Stephen Lim, Alan Lopez, Michael MacIntyre, L. Marczak, N. Marquez, A. Mokdad, Christine Pinho, F. Pourmalek, J. Salomon, J. Sanabria, Logan Sandar, B. Sartorius, S. Schwartz, K. Shackelford, K. Shibuya, J. Stanaway, C. Steiner, Jiandong Sun, Ken Takahashi, S. Vollset, T. Vos, Joseph Wagner, Haidong Wang, R. Westerman, H. Zeeb, Leo Zoeckler, F. Abd-Allah, M. Ahmed, S. Alabed, N. Alam, S. Aldhahri, Girma Alem, Mulubirhan Alemayohu, R. Ali, Rajaa Al-Raddadi, Azmeraw Amare, Y. Amoako, A. Artaman, H. Asayesh, N. Atnafu, A. Awasthi, H. Saleem, A. Barać, Neeraj Bedi, I. Benseñor, A. Berhane, E. Bernabé, B. Betsu, A. Binagwaho, D. Boneya, Ismael Campos-Nonato, C. Castañeda-Orjuela, F. Catalá-López, P. Chiang, C. Chibueze, Abdulaal Chitheer, J. Choi, B. Cowie, S. Damtew, J. Neves, S. Dey, S. Dharmaratne, P. Dhillon, E. Ding, T. Driscoll, D. Ekwueme, A. Endries, M. Farvid, F. Farzadfar, João Fernandes, F. Fischer, Tsegaye G/hiwot, A. Gebru, S. Gopalani, A. Hailu, M. Horino, N. Horita, A. Husseini, I. Huybrechts, M. Inoue, F. Islami, M. Jakovljevic, S. James, Mehdi Javanbakht, S. Jee, A. Kasaeian, Muktar Kedir, Y. Khader, Y. Khang, Daniel Kim, J. Leigh, S. Linn, R. Lunevicius, Hassan Razek, R. Malekzadeh, D. Malta, W. Marcenes, D. Markos, Y. Melaku, K. Meles, W. Mendoza, Desalegn Mengiste, T. Meretoja, T. Miller, K. Mohammad, A. Mohammadi, S. Mohammed, M. Moradi-Lakeh, G. Nagel, D. Nand, Q. Nguyen, Sandra Nolte, F. Ogbo, K. Oladimeji, Eyal Oren, Mahesh Pa, Eun‐Kee Park, David Pereira, D. Plass, M. Qorbani, A. Radfar, Anwar Rafay, Mahfuzar Rahman, S. Rana, K. Søreide, Maheswar Satpathy, M. Sawhney, S. Sepanlou, M. Shaikh, Jun She, I. Shiue, H. Shore, M. Shrime, S. So, S. Soneji, V. Stathopoulou, K. Stroumpoulis, M. Sufiyan, Bryan Sykes, R. Tabarés-Seisdedos, Fentaw Tadese, B. Tedla, G. Tessema, J. Thakur, B. Tran, K. Ukwaja, B. Uzochukwu, V. Vlassov, E. Weiderpass, Mamo Terefe, Henock Yebyo, H. Yimam, N. Yonemoto, M. Younis, Chuanhua Yu, Z. Zaidi, M. Zaki, Z. Zenebe, C. Murray, M. Naghavi (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease StudyJAMA Oncology, 3
Journal of Health and Development, 1
CA: A Cancer Journal for Clinicians, 55
H. Salehiniya, Sakineh Dashdebi, H. Rafiemanesh, A. Mohammadian-Hafshejani, M. Enayatrad (2016)
Time Trend Analysis of Cancer Incidence in Caspian Sea, 2004 – 2009: A Population-based Cancer Registries Study (northern Iran)Caspian Journal of Internal Medicine, 7
D. Rice (2000)
Cost of illness studies: what is good about them?Injury Prevention, 6
Value in Health, 17
(2019)
Cancer statistics in IR Iran in 2018
SH.Semnani, AA.Keshtkar (2003)
Assessing of equality on health care cost in Gorgan population laboratory studyJournal of Gorgan University of Medical Sciences, 5
Value in Health, 18
Asian Pacific Journal of Cancer Prevention, 6
Iranian Journal of Epidemiology, 8
Lindsey Torre, F. Bray, R. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal (2015)
Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 65
Bahmei Jamshid, R. Hamed, J. Saleh, H. Mostafa (2015)
EXAMINATION OF MEDICAL AND NON-MEDICAL DIRECT COSTS OF OUTPATIENTS AND HOSPITALIZED CANCER PATIENTS IN SHIRAZ, IRAN, 14
S. Asefzadeh, M. Alijanzadeh, F. Peyravian (2014)
Out of pocket expenditures for outpatient clinics in teaching hospitals, 13
L. Gordon, M. Ferguson, S. Chambers, J. Dunn (2009)
Fuel, beds, meals and meds: Out-of-pocket expenses for patients with cancer in rural Queensland, 33
F. Kamangar, G. Dores, W. Anderson (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 14
Annals of Oncology, 17
Współczesna Onkologia, 47
Zeinab Almasi, H. Rafiemanesh, H. Salehiniya (2015)
Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran.Asian Pacific journal of cancer prevention : APJCP, 16 7
Iranian Journal of Diabetes and Metabolism, 1
(2018)
Cancer, fact sheets
M. Davari, F. Yazdanpanah, Abolfazl Aslani, M. Hosseini, A. Nazari, Fairborz Mokarian (2013)
The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in IsfahanInternational Journal of Preventive Medicine, 4
P. Bertuccio, L. Chatenoud, F. Levi, D. Praud, J. Ferlay, E. Negri, M. Malvezzi, C. Vecchia (2009)
Recent patterns in gastric cancer: A global overviewInternational Journal of Cancer, 125
K. Shermock, C. Asche, B. Seal, C. Kreilick, Jane Chang, E. Zagadailov, J. Kish, M. Eaddy, F. Xia (2015)
Cost of Care for Gastric Cancer In Patients With and Without MetastasesValue in Health, 18
Rahimi Farzad, Heidar Mohammad (2012)
Time Trend Analysis of Stomach Cancer Incidence in the West of Iran, 1
(2006)
The burden of disease and mortality by condition: data, methods and results for 2001 of article
A. Miners (2012)
Estimating ‘Costs’ for Cost-Effectiveness AnalysisPharmacoEconomics, 26
Journal of Clinical Oncology, 29
Hosseinnezhad Arash, Ardeshir Bagher (2001)
COST ANALYSIS OF SCREENING AND DIAGNOSTIC METHODS IN GESTATIONAL DIABETES MELLITUSIranian Journal of Diabetes and Metabolism, 1
(2005)
Characteristics of cancer patients' out-of-pocket costs in Ontario
S. Saadat, M. Yousefifard, Hadi Asady, Ali Jafari, M. Fayaz, M. Hosseini (2015)
The Most Important Causes of Death in Iranian Population; a Retrospective Cohort StudyEmergency, 3
M. Davari, M. Maracy, M. Emami, D. Taheri, Abolfazl Aslani, M. Givi, S. Massah (2012)
The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in IsfahanInternational Journal of Preventive Medicine, 3
F. Noori, K. Naieni, A. Haghdoost, A. Emami (2012)
Cost Analysis for Cancer Subgroups in Kerman, IRANiranian journal of epidemiology, 8
G. Murphy, R. Pfeiffer, M. Camargo, C. Rabkin (2009)
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.Gastroenterology, 137 3
Farahnaz Nourozinia, Yousef Rasmi, Mohammad Otarod, M. Golizadeh, Mohammad-Hassan Khadem-Ansari (2013)
EPIDEMIOLOGY AND HISTOPATHOLOGY OF GASTRIC CANCER IN URMIAUrmia medical journal, 24
G. Abedi, Roya Malekzadeh, M. Moosazadeh, Ehsan Abedini, E. Hasanpoor (2019)
Nurses' Perspectives on the Impact of Marketing Mix Elements (7Ps) on Patients' Tendency to Kind of HospitalEthiopian Journal of Health Sciences, 29
A. Sadjadi, M. Nouraie, M. Mohagheghi, Alireza Mousavi-Jarrahi, Reza Malekezadeh, D. Parkin (2005)
Cancer occurrence in Iran in 2002, an international perspective.Asian Pacific journal of cancer prevention : APJCP, 6 3
Gastric cancer is the fourth most common cancer and the leading cause of death after lung cancer in the world. Considering the economic burden of cancers and their impact on household welfare, this study aims to estimate the cost of gastric cancer in Tabriz (Northwest city of Iran) in 2017.Design/methodology/approachThis was an incidence-based cost of illness study which was conducted from the perspective of society with a bottom-up costing approach. The inclusion criteria for the study were all patients (n = 118) with gastric cancer at the period of the first six months after diagnosis that 102 patients participated. Data were analyzed using SPSS software version 22.FindingsThe mean medical direct cost was US$3288.02, 18.19 per cent paid by the patient and 81.81 per cent paid by insurance organizations and governmental subsidies. The estimated out of pocket rate was 18.19 per cent. The mean non-medical direct cost estimated at US$377.54. The mean total direct cost was US$3665.56, 26.61 per cent paid by the patient. The mean indirect cost estimated at US$505.41 and the mean total cost was US$4170.97, 35.5 per cent which imposed on the patient. The mean total cost of gastric cancer within the first six months after diagnosis was equivalent to 0.81 GDP per capita.Originality/valueBased on the findings, gastric cancer is a highly costly disease that despite insurance coverage imposes a high economic burden on the patients and their families.
International Journal of Pharmaceutical and Healthcare Marketing – Emerald Publishing
Published: Oct 4, 2019
Keywords: Burden of disease; Cost of illness; Gastric cancer; Stomach cancer
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.